Products

Limevpn

Simple VPN. Stable Access. No Lock-In.

limevpn.com Security & Privacy / VPN & Privacy Protection

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Sep 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
Subscription model, plan pricing not identified yet
Creators
limaborat
@limaborat
Launched
8y ago
2017-12-06 · Est.

Traffic

Monthly visitsData through Sep 2026 · Oct 2026 pending

Marketing moves

Launches, search & content, referrals, promotions

  • Launched on BetaListLaunch

    Limevpn – VPN service provider that grants secure and encrypted connections — VPN service provider that grants secure and encrypted connections

    Dec 6, 2017 · 8y agoLaunch page

Traffic sources

Sep 2026

Traffic breakdown

Channels

  • Direct39%
  • Organic Search31%
  • Referrals10%
  • Social6%
  • Other13%

Countries

  • United States38%
  • Vietnam23%
  • Germany18%
  • India17%
  • United Kingdom4%

Search

Domain authority —Domain registered 2011-02-24

KeywordMonthly volume
is discord down356.4K
is netflix down?1,320
aimilivpn300
is prime video down280
emaiil data breach checker—

Traffic data: Vaneform

Pricing

Pricing page does not list plan prices.

Trial: None · Observed 2026-11-04 · Pricing page

Pages & changes

Tracked since 2026-08-13

Key pages

Weekly snapshots
limevpn.com/ Snapshot 2026-11-04

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does Limevpn get?
Vaneform estimates <5K website visits in 2026-09. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Limevpn and what platforms does it support?
Limevpn is catalogued under VPN & Privacy Protection: Simple VPN. Stable Access. No Lock-In.. Supported platforms: Mobile App.

Related products in this category

Security & Privacy / VPN & Privacy Protection

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.